Publication | Open Access
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
220
Citations
8
References
2019
Year
Cancer Research UK, the National Health and Medical Research Council Australia, Breast Cancer Research Foundation, Sanofi Aventis, and AstraZeneca.
| Year | Citations | |
|---|---|---|
Page 1
Page 1